Angela Maria Arenas Velásquez , Irwin Alexander Patino Linares , Lawrence D. Gaspers , Paula J. Bartlett , Jecika M. Velasques , Adelino V.G. Netto , Andrew P. Thomas , Marcia A.S. Graminha
{"title":"The binuclear cyclopalladated complex CP2 is targeting ubiquinol-cytochrome c reductase (complex III) of Leishmania amazonensis","authors":"Angela Maria Arenas Velásquez , Irwin Alexander Patino Linares , Lawrence D. Gaspers , Paula J. Bartlett , Jecika M. Velasques , Adelino V.G. Netto , Andrew P. Thomas , Marcia A.S. Graminha","doi":"10.1016/j.ijpddr.2024.100574","DOIUrl":null,"url":null,"abstract":"<div><div>Leishmaniasis is a neglected disease that remains with a limited number of drugs available for chemotherapy and has an increased drug resistance that affects treatment outcomes. Metal-based drugs such as cyclopalladated complex [Pd(dmba)(μ-N<sub>3</sub>)]<sub>2</sub> (<strong>CP2</strong>), a <em>Leishmania</em> topoisomerase IB inhibitor involved in calcium dysregulation and mitochondrial dysfunction of the parasite, had been an alternative to outline the appearance of chemoresistance. To identify new molecular targets and point out possible resistance mechanisms, a <strong>CP2</strong>-resistant <em>Leishmania amazonensis</em> (<em>LaR</em>) was selected by stepwise exposure to increasing drug pressure until a line capable of growth in 13.3 μM <strong>CP2</strong>. <em>LaR</em> IC<sub>50</sub> value was 52.4 μM (4-fold higher than <em>L. amazonensis</em>–wild type, <em>La</em>). <em>LaR</em> promastigotes were cross-resistant to other DNA topoisomerase I inhibitors (camptothecin) and more susceptible to anti-leishmanial drugs pentamidine and miltefosine. A protective effect on cell viability was observed by pretreating the parasite with Ca<sup>2+</sup> channel blockers followed by <strong>CP2</strong> in <em>La</em> but not in <em>LaR</em>. Analyses of the cell viability of <em>La</em> and <em>LaR</em> using electron transport chain (ETC) inhibitors demonstrated that <em>La</em> is more sensitive than <em>LaR</em>. The studies of mitochondrial oxygen consumption demonstrated that <em>LaR</em> is less susceptible to complex III (ubiquinol-cytochrome <em>c</em> reductase – CcR) inhibitor, antimycin A (AA). CcR activities of <em>La</em> and <em>LaR</em> were equal for both strains in the absence of <strong>CP2</strong> and significantly decreased, 69 % for <em>La</em> and 51 % for <em>LaR</em>, in the presence of <strong>CP2</strong>. This resistance is attributed to overexpression of CcR, confirmed by the RT-qPCR. CcR inhibition by <strong>CP2</strong> leads the parasite to increase the reactive oxygen species (ROS) production, principally in <em>La.</em> Therefore, in this work, we suggested that CcR is the main target of <strong>CP2</strong> in the mitochondria, acting to inhibit mitochondria respiratory, and the <em>LaR</em> mutant has increased activity of CcR, which reduces the formation of ROS.</div></div>","PeriodicalId":13775,"journal":{"name":"International Journal for Parasitology: Drugs and Drug Resistance","volume":"27 ","pages":"Article 100574"},"PeriodicalIF":4.1000,"publicationDate":"2024-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748178/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal for Parasitology: Drugs and Drug Resistance","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211320724000551","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Leishmaniasis is a neglected disease that remains with a limited number of drugs available for chemotherapy and has an increased drug resistance that affects treatment outcomes. Metal-based drugs such as cyclopalladated complex [Pd(dmba)(μ-N3)]2 (CP2), a Leishmania topoisomerase IB inhibitor involved in calcium dysregulation and mitochondrial dysfunction of the parasite, had been an alternative to outline the appearance of chemoresistance. To identify new molecular targets and point out possible resistance mechanisms, a CP2-resistant Leishmania amazonensis (LaR) was selected by stepwise exposure to increasing drug pressure until a line capable of growth in 13.3 μM CP2. LaR IC50 value was 52.4 μM (4-fold higher than L. amazonensis–wild type, La). LaR promastigotes were cross-resistant to other DNA topoisomerase I inhibitors (camptothecin) and more susceptible to anti-leishmanial drugs pentamidine and miltefosine. A protective effect on cell viability was observed by pretreating the parasite with Ca2+ channel blockers followed by CP2 in La but not in LaR. Analyses of the cell viability of La and LaR using electron transport chain (ETC) inhibitors demonstrated that La is more sensitive than LaR. The studies of mitochondrial oxygen consumption demonstrated that LaR is less susceptible to complex III (ubiquinol-cytochrome c reductase – CcR) inhibitor, antimycin A (AA). CcR activities of La and LaR were equal for both strains in the absence of CP2 and significantly decreased, 69 % for La and 51 % for LaR, in the presence of CP2. This resistance is attributed to overexpression of CcR, confirmed by the RT-qPCR. CcR inhibition by CP2 leads the parasite to increase the reactive oxygen species (ROS) production, principally in La. Therefore, in this work, we suggested that CcR is the main target of CP2 in the mitochondria, acting to inhibit mitochondria respiratory, and the LaR mutant has increased activity of CcR, which reduces the formation of ROS.
期刊介绍:
The International Journal for Parasitology – Drugs and Drug Resistance is one of a series of specialist, open access journals launched by the International Journal for Parasitology. It publishes the results of original research in the area of anti-parasite drug identification, development and evaluation, and parasite drug resistance. The journal also covers research into natural products as anti-parasitic agents, and bioactive parasite products. Studies can be aimed at unicellular or multicellular parasites of human or veterinary importance.